Reagent Labs turns experimental data from deep tech, biotech and hard tech into revenue, whether you're a CRO generating it every week or a company winding down with years of it on a server. We license it to the teams training the models that will make the next discoveries.
Operating companies, CROs & service labs
License the data you already generate, quarter after quarter. Licenses are non-exclusive by default, so you keep using your data and keep running your business. Where the data belongs to your clients, we only license it with their consent.
Companies winding down or already closed
Turn years of experiments into proceeds for founders, investors and creditors before the servers go dark, with an upfront payment and a share of future licenses.
You share the data. We handle the inventory, the legal work and the packaging. You get paid when it's licensed, and again each time it's licensed after that.
Your data
ELN & LIMS exports Raw instrument files Imaging & test logs Failed runsReagent Labs
Model labs
A licensed corpus with a provenance record attached.
You receive
Revenue every time your data is licensed
HTS, dose-response, ADMET, binding.
Sequence-to-function, expression, stability.
High-content, microscopy, histology.
Synthesis routes, yields, characterization.
Field trials, phenotyping, soil & crop genomics.
Thermal-vac, vibration, flight telemetry, propulsion tests.
Test campaigns, failure analysis, time series.
Detection, diagnostics, countermeasures. Screened case by case.
Rarely published, so some of the scarcest data there is.
Yes. Most operating partners license non-exclusively, so they keep full use of their data and earn each time it's licensed. CROs can license data they own outright, such as method development, validation and reference runs, and client data where the client agrees.
Usually, yes, as long as the company (or its assignee or trustee) owns the data and it isn't restricted by partner contracts, lender liens or consent terms. We check this before making an offer. Start early: data is easiest to recover before servers are switched off and the team disperses.
The company does, not its founders or scientists. In an assignment for the benefit of creditors or a bankruptcy, the assignee or trustee controls it. Venture lenders often hold a lien over it too.
It depends on scale, uniqueness, annotation quality and how clean the rights are. Datasets are often worth more combined into a larger corpus than sold alone. We give an indicative range after a short review.
Yes. Negative results are rarely published, which makes them some of the most valuable data for training scientific AI.
These often come with restrictions on who owns the data and whether it can be resold. We review the agreements, and some datasets can't be sold.
Not identifiable patient data. We focus on non-human experimental, instrument, materials and hardware data.
Tell us what you have. We'll come back with an indicative range and a structure that fits.